Skip to content
healthcare.dev

Nintedanib

NDC 69097-641, Nintedanib, capsule, from Cipla USA Inc..

Product NDC
69097-641
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212609
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-641 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NINTEDANIB ESYLATE100 mg/1

Pharmacologic classes

Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]

Package NDCNDC-11Package
69097-641-036909706410360 CAPSULE in 1 BOTTLE (69097-641-03)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4d017c42-a823-452d-bc6f-0491dd9823e3

Use it

Look up 69097-641 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-641 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-641. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.